• Health & Medicine

Behind the scenes with the unsung heroes of cancer clinical trials – Part 3

We speak to Amanda Watson, research nurse on the National Lung Matrix Trial, about what her job involves. We speak to Amanda Watson, research nurse on the National Lung Matrix Trial, about what her job involves.

22 May 2017

• Health & Medicine

Targeted drug delays relapse of intermediate-stage lung cancer

A drug holds lung cancer at bay longer after surgery than standard chemotherapy, according to unpublished results of a new trial in China. A drug holds lung cancer at bay longer after surgery than standard chemotherapy, according to unpublished results of a new trial in China.

19 May 2017

• Health & Medicine

Competition between immune cells could explain why some immunotherapy drugs fail

New images may have uncovered why in some cases cancers don’t respond to certain immunotherapy drugs. New images may have uncovered why in some cases cancers don’t respond to certain immunotherapy drugs.

12 May 2017

• Health & Medicine

Taking a potential new breast cancer treatment from the lab to the clinic

Our research has led to new clinical trials testing a combination of hormone therapies in women with early, double-positive breast cancer. Our research has led to new clinical trials testing a combination of hormone therapies in women with early, double-positive breast cancer.

5 May 2017

• Health & Medicine
• Science & Technology

Experimental blood test predicts advanced prostate cancer outcome

A blood test could help predict which advanced prostate cancer patients are likely to do best when treated with certain targeted treatments. A blood test could help predict which advanced prostate cancer patients are likely to do best when treated with certain targeted treatments.

4 May 2017

• Health & Medicine

Testing a new immunotherapy treatment for neuroblastoma

A researcher explains an early stage clinical trial testing the potential of a new type of immunotherapy to treat neuroblastoma. A researcher explains an early stage clinical trial testing the potential of a new type of immunotherapy to treat neuroblastoma.

3 May 2017

• Health & Medicine
• Science & Technology

Tracking unstable chromosomes helps predict lung cancer’s return

The first findings from the Cancer Research UK-funded TRACERx* lung cancer study show how tracking tumour evolution can help predict relapse. The first findings from the Cancer Research UK-funded TRACERx* lung cancer study show how tracking tumour evolution can help predict relapse.

26 April 2017

• Health & Medicine

CRISPR genome editing and immunotherapy – the early adopter

How is CRISPR genome editing helping harness the power of immunotherapy? How is CRISPR genome editing helping harness the power of immunotherapy?

21 April 2017

• Science & Technology
• Health & Medicine

Taking advantage of cancers’ abnormal metabolism could lead to a new way to ‘starve’ tumours

Our researchers in Glasgow might have found a way to shut down certain cancer cells’ fuel supply with a specially designed diet. Our researchers in Glasgow might have found a way to shut down certain cancer cells’ fuel supply with a specially designed diet.

19 April 2017

• Health & Medicine
• Science & Technology

News digest – immunotherapies showing promise, breast cancer drug approved for Scotland, childhood cancer rates, and… killer sofas?

Immunotherapies show promise but not for every tumour, calls for boys to get the HPV vaccine and... what's killer about sofas? Find out in the news digest. Immunotherapies show promise but not for every tumour, calls for boys to get the HPV vaccine and... what's killer about sofas? Find out in the news digest.

14 April 2017

• Health & Medicine
• Science & Technology

Blood tests, microbes, immunotherapy and more: AACR 2017’s hottest topics

At AACR 2017, thousands of doctors and scientists shared progress in cancer research. Read about the hottest topics. At AACR 2017, thousands of doctors and scientists shared progress in cancer research. Read about the hottest topics.

13 April 2017

• Health & Medicine

Immunotherapy drug too costly for head and neck cancer

An immunotherapy drug is too expensive to be given to NHS patients with head and neck cancers in England, according to the NHS drugs watchdog. An immunotherapy drug is too expensive to be given to NHS patients with head and neck cancers in England, according to the NHS drugs watchdog.

12 April 2017